Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study). (Q39929092)
Jump to navigation
Jump to search
scientific article published on 18 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study). |
scientific article published on 18 April 2010 |
Statements
1 reference
Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study). (English)
1 reference
Jean-François Morère
1 reference
Jeanne-Marie Bréchot
1 reference
Virginie Westeel
1 reference
Valerie Gounant
1 reference
Bernard Lebeau
1 reference
Fabien Vaylet
1 reference
Fabrice Barlési
1 reference
Thierry Urban
1 reference
Pierre-Jean Souquet
1 reference
Didier Debieuvre
1 reference
Laurence Baudrin
1 reference
Gérard Zalcman
1 reference
Franck Morin
1 reference
Bernard Milleron
1 reference
Denis Moro-Sibilot
1 reference
18 April 2010
1 reference
1 reference
70
1 reference
3
1 reference
301-307
1 reference
Identifiers
1 reference
1 reference